H02 Stock Overview
Manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
Haw Par Corporation Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | S$10.45 |
52 Week High | S$10.57 |
52 Week Low | S$9.44 |
Beta | 0.38 |
11 Month Change | 4.08% |
3 Month Change | 6.52% |
1 Year Change | 6.31% |
33 Year Change | -13.78% |
5 Year Change | -25.36% |
Change since IPO | 392.01% |
Recent News & Updates
Haw Par Corporation Limited (SGX:H02) Might Not Be As Mispriced As It Looks
Sep 08Haw Par (SGX:H02) Has Announced A Dividend Of SGD0.20
Apr 25Recent updates
Haw Par Corporation Limited (SGX:H02) Might Not Be As Mispriced As It Looks
Sep 08Haw Par (SGX:H02) Has Announced A Dividend Of SGD0.20
Apr 25We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Haw Par Corporation Limited's (SGX:H02) CEO For Now
Apr 16Haw Par (SGX:H02) Has Announced A Dividend Of SGD0.20
Apr 02Haw Par (SGX:H02) Is Increasing Its Dividend To SGD0.20
Aug 14Haw Par (SGX:H02) Could Easily Take On More Debt
Jun 17Haw Par (SGX:H02) Has Announced A Dividend Of SGD0.15
Apr 04Haw Par (SGX:H02) Has A Rock Solid Balance Sheet
Oct 20Haw Par (SGX:H02) Will Pay A Dividend Of SGD0.15
Aug 12Haw Par (SGX:H02) Will Pay A Dividend Of S$0.15
Apr 28Haw Par (SGX:H02) Is Due To Pay A Dividend Of S$0.15
Apr 06Haw Par (SGX:H02) Has Affirmed Its Dividend Of S$0.15
Feb 27Haw Par (SGX:H02) Will Pay A Dividend Of S$0.15
Aug 23Is Haw Par Corporation Limited (SGX:H02) Popular Amongst Institutions?
Jan 24Should Haw Par Corporation Limited (SGX:H02) Be Part Of Your Dividend Portfolio?
Jan 03Haw Par Corporation Limited (SGX:H02) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?
Dec 13Shareholders Of Haw Par (SGX:H02) Must Be Happy With Their 50% Return
Nov 23Shareholder Returns
H02 | SG Pharmaceuticals | SG Market | |
---|---|---|---|
7D | 3.2% | -2.9% | 0.3% |
1Y | 6.3% | 11.5% | 4.5% |
Return vs Industry: H02 underperformed the SG Pharmaceuticals industry which returned 11.5% over the past year.
Return vs Market: H02 exceeded the SG Market which returned 4.5% over the past year.
Price Volatility
H02 volatility | |
---|---|
H02 Average Weekly Movement | 2.0% |
Pharmaceuticals Industry Average Movement | 5.5% |
Market Average Movement | 5.0% |
10% most volatile stocks in SG Market | 15.5% |
10% least volatile stocks in SG Market | 2.4% |
Stable Share Price: H02 has not had significant price volatility in the past 3 months.
Volatility Over Time: H02's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1969 | n/a | Ee Lim Wee | www.hawpar.com |
Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. The company operates through three segments: Healthcare, Investments, and Others. It manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands; and invests in quoted securities.
Haw Par Corporation Limited Fundamentals Summary
H02 fundamental statistics | |
---|---|
Market cap | S$2.31b |
Earnings (TTM) | S$234.43m |
Revenue (TTM) | S$239.06m |
9.9x
P/E Ratio9.7x
P/S RatioIs H02 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
H02 income statement (TTM) | |
---|---|
Revenue | S$239.06m |
Cost of Revenue | S$102.66m |
Gross Profit | S$136.40m |
Other Expenses | -S$98.03m |
Earnings | S$234.43m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.06 |
Gross Margin | 57.06% |
Net Profit Margin | 98.06% |
Debt/Equity Ratio | 1.0% |
How did H02 perform over the long term?
See historical performance and comparison